Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatitis A-related acute liver failure and severe acute pancreatitis with prolonged cholestasis.

Tropical doctor·2026
Same author

Fructose malabsorption associated with functional abdominal bloating: Case-control study.

World journal of gastrointestinal pharmacology and therapeutics·2026
Same author

Outcomes of Nucleos(t)ide Analogue Discontinuation in Noncirrhotic Patients With Chronic Hepatitis B: A Retrospective Study.

Cureus·2026
Same author

Bleeding ectopic varices at hepaticojejunostomy.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Reply to evolving strategies for ERCP in pregnant patients.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

A fluid dynamics perspective on common bile duct dilatation in patients with low cystic duct insertion.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026

Related Experiment Video

Updated: May 18, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculosis and liver disease: management issues.

Ujjwal Sonika1, Premashis Kar

  • 1Department of Medicine, Maulana Azad Medical College, New Dehi, India.

Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation
|October 3, 2012
PubMed
Summary

Tuberculosis (TB) can affect the liver directly or indirectly through drug toxicity. Managing TB in patients with chronic liver disease requires careful monitoring and adjusted anti-TB drug regimens to minimize liver injury.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Pulmonology

Background:

  • Tuberculosis is a significant health concern in India, with complex interactions with liver health.
  • Liver disease can stem from hepatic tuberculosis, anti-tubercular drug toxicity, or tuberculosis developing in patients with pre-existing liver conditions.

Purpose of the Study:

  • To explore the multifaceted relationship between tuberculosis and liver disease.
  • To outline management strategies for tuberculosis affecting the liver and for treating tuberculosis in patients with chronic liver disease.

Main Methods:

  • Review of the three forms of hepatic tuberculosis: diffuse hepatic involvement, granulomatous hepatitis, and focal tuberculoma/abscess.
  • Analysis of treatment approaches for different hepatic tuberculosis presentations.

Related Experiment Videos

Last Updated: May 18, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

  • Discussion of challenges and safety considerations for anti-tubercular drug use in patients with chronic liver disease.

    • Main Results:

    • Disseminated tuberculosis with liver involvement is treated with standard pulmonary TB regimens.
    • Granulomatous hepatitis and hepatic tuberculomas are managed similarly to other extrapulmonary TB lesions.
    • Treating tuberculosis in patients with chronic liver disease necessitates careful monitoring for drug-induced hepatitis, with potential for safe drug use through regimen adjustment.

    Conclusions:

    • Hepatic tuberculosis presents in various forms, each requiring specific management considerations.
    • Anti-tubercular drug therapy in patients with chronic liver disease can be managed safely by adjusting the number of hepatotoxic drugs and close patient monitoring.
    • Effective management hinges on balancing TB treatment efficacy with the risk of exacerbating liver disease.